ARID1A is highly mutated in EBV-positive gastric cancer, indicating that INF-α and INF-β may be induced by EBV infection as well as by ARID1A inactivation itself in ARID1A-mutated gastric cancer. This evidence concerns the gene IFNA17 and gastric cancer.